Publication details
Doporučené postupy Evropské kardiologické společnosti pro kardioonkologii z roku 2022 vypracované ve spolupráci s European Hematology Association (EHA), European Society for Therapeutic Radiology and Oncology (ESTRO) a International Cardio-Oncology Society (IC-OS)
| Title in English | 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS) |
|---|---|
| Authors | |
| Year of publication | 2023 |
| Type | Article in Periodical |
| Magazine / Source | cor et Vasa |
| MU Faculty or unit | |
| Citation | |
| web | https://e-coretvasa.cz/artkey/cor-202302-0005_2022-esc-guidelines-on-cardio-oncology-developed-in-collaboration-with-the-european-hematology-association-eh.php |
| Doi | http://dx.doi.org/10.33678/cor.2023.032 |
| Keywords | amyloid light-chain cardiac amyloidosis; androgen deprivation therapy; anthracycline; arrhythmias; atrial fibrillation; biomarkers; cancer; cancer survivors; carcinoid syndrome; cardiac magnetic resonance; cardiac tumor |
| Description | Recommendations summarise and evaluate the available evidence to help health professionals design the best strategies treatment for an individual patient with a given condition. Recommendations should facilitate health professionals' decision-making in their their daily practice. However, they do not replace the patient-physician relationship. Final decisions regarding an individual patient must be made by the responsible healthcare professional(s) on the basis of what they consider to be circumstances. These decisions are made after consultation with the patient. The recommendations are intended for for use by healthcare professionals. To ensure that all users have access to the latest recommendations, the European Society of Cardiology ESC recommendations freely available. |